7 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... risk stratification ... #Diagnosis #Hematology ... CHADS2VASc #HASBLED #Comparison ... #Score #Risk #Stroke
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... Hemoptysis, GI Bleeding ... fatigue; Increases risk ... #Indications #Pharmacology ... #hematology
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
scores for stroke risk ... and bleed risk ... S Stroke 1 B Bleeding ... CHADS2VASc #HASBLED #Comparison ... AFib #Diagnosis #Hematology
Hydroxychloroquine - Risks and Benefits in Lupus
Benefits:
↓ Disease activity, ↓ Flare, ↓ Damage, ↓ Corticosteroid dose,
Hydroxychloroquine - Risks ... other medications leading ... caution] and G6PD deficiency ... Benefits #Lupus #pharmacology ... #sideeffects #rheumatology
Low Alkaline Phosphatase - Hypophosphatasia 

Is Low Alkaline Phosphatase Of Clinical Importance?

ALP enzyme- Discovered in 1923
Low
prematurely • risk ... • Vitamin C deficiency ... Pernicious anemia/B12 deficiency ... ) - Waddling gait ... Hyophosphatasia #hepatology
Medications to Avoid in Patients with G6PD Deficiency Due to Risk of Hemolysis
 - Chloroquine (Aralen)*
Patients with G6PD Deficiency ... Due to Risk of ... Synthetase #G6PD #Deficiency ... Differential #Diagnosis #Pharmacology ... #Hematology
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
carries a variable risk ... or folic acid deficiency ... treatments • Copper deficiency ... and reducing the risk ... Syndromes #diagnosis #hematology